Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axatilimab phase Ib/II study in Chinese patients with recurrent or refractory active chronic graft-versus-host disease
CTR20250308Phase 2Active
- Sponsor
- Incyte
- Start
- Jun 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of axatilimab in chronic graft-versus-host disease (cGVHD), sponsored by Incyte. Started Jun 2025; status: active.
02
Drugs
axatilimab
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on CTR20250308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250308.